{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-098068","form_type":"8-K","ticker":"SRTS","cik":"0001494891","company_name":"Sensus Healthcare, Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.581907+00:00","generated_at":"2026-05-30T00:25:32.730763+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sensus Healthcare Q3 2024 revenue doubles to $8.8M; net income of $0.07 per diluted share","bullets":["Revenue $8.8M (+127% YoY); net income $1.2M vs net loss $1.5M in Q3 2023.","Shipped 27 systems (11 in Q3 2023); cash $22.6M, no debt.","Adjusted EBITDA $1.6M (negative $1.7M a year ago).","Signed Fair Deal Agreement with Platinum Dermatology (130+ clinics); 22 agreements since March 2024.","Sold SRT system to Providence Swedish Hospital; expects recurring revenue from Fair Deal Agreements in 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-098068","json":"https://secwatch.observer/filing/0001213900-24-098068.json","markdown":"https://secwatch.observer/filing/0001213900-24-098068.md","text":"https://secwatch.observer/filing/0001213900-24-098068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000121390024098068/0001213900-24-098068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000121390024098068/ea0221149-8k_sensus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:25:32.730763+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}